Mesothelial cell proliferation: a nonspecific response to lung injury associated with fibrosis.
An early proliferative response of mesothelial and subpleural cells has been reported in animals after inhalation or intratracheal (I.T.) instillation to the lung of long asbestos fibers, which also induce pulmonary fibrosis. To determine whether this cell proliferation is directly related to asbestos exposure or is a nonspecific response to injury, we examined [3H]thymidine (3HT) uptake by cells at the pleura after exposing mice to 5 days of hyperoxia, to intravenous (I.V.) (3 mg) or I.T. (0.15 mg) bleomycin, to I.T. (1 mg) silica, and to I.T. (0.1 mg) crocidolite asbestos of mixed length. All exposures induced acute lung injury, as shown by high levels of protein in lavage fluid. After hyperoxia, the percentage of total lung cells labeled by 3HT in autoradiographs was high for only a few days, as repair took place with no increase in fibroblast growth and no subsequent development of fibrosis. Particle or bleomycin exposure induced a prolonged increase in 3HT uptake with enhanced fibroblast labeling over a 4- to 6-wk period. In each case, labeled subpleural cells, mainly fibroblasts, increased up to 10-fold in the first 2 to 4 wk. At the same time, 3HT uptake by mesothelial cells ranged from 1.4 to 3% compared with almost zero in controls and in oxygen-exposed mice after a few days upon return to air. These results indicate that mesothelial and subpleural cell proliferation occurs after various types of injury to the lung. The close temporal association between 3HT uptake by mesothelial cells and fibroblasts during the reparative phase suggests that mesothelial cells may respond to the same cytokines that trigger interstitial fibrosis.
Adamson
I Y
IY
Department of Pathology, University of Manitoba, Winnipeg, Canada.
Bakowska
J
J
Bowden
D H
DH
D000818:Animals; D017638:Asbestos, Crocidolite / Q000008:administration & dosage / Q000633:toxicity*; D001345:Autoradiography; D001761:Bleomycin / Q000633:toxicity*; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002455:Cell Division; D004847:Epithelial Cells; D005347:Fibroblasts / Q000166:cytology; D006909:Hydroxyproline / Q000032:analysis; D007275:Injections, Intravenous; D008168:Lung / Q000166:cytology* / Q000473:pathology; D008297:Male; D051379:Mice; D010100:Oxygen / Q000633:toxicity; D010994:Pleura / Q000166:cytology* / Q000473:pathology; D011658:Pulmonary Fibrosis / Q000209:etiology / Q000473:pathology*; D012822:Silicon Dioxide / Q000633:toxicity*; D013936:Thymidine / Q000378:metabolism
D001761:Bleomycin; D017638:Asbestos, Crocidolite; D012822:Silicon Dioxide; D006909:Hydroxyproline; D010100:Oxygen; D013936:Thymidine